A discovery at Hudson Institute more than 20 years ago is still sparking new medical insights, with researchers at a major US University using it to uncover vital facts about sexually transmitted disease (STI).
A team at UMass Chan Medical School used an Australian-developed mouse model to test their theory that Interferon Epsilon (IFNε) plays a crucial role in the presence of gonorrhoea - opening the door to potential treatments and more.
Professor Paul Hertzog discovered IFNε in 2004, and since 2013, when he first identified its function, he and his team at Hudson Institute of Medical Research have shown that it acts as a natural booster of immunity to infections, with potential uses in treating a range of conditions including ovarian cancer and endometriosis.
